Tuomo Alanko
5PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 05, 2025
The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial.Matthew Stephen Block, James Hugo Armstrong Clubb, Johanna Mäenpää
|Jan 27, 2025
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial.Santeri A Pakola, James H A Clubb, Tatiana V Kudling
|Mar 28, 2024
Safety, Efficacy, and Biological Data of T-Cell-Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial.Santeri A Pakola, Katriina J Peltola, James H A Clubb
|Oct 28, 2020
Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study.Sanna Iivanainen, Tuomo Alanko, Pia Vihinen
Pageof 1
Frequent Collaborators
4 joint publications
Akseli Hemminki
4 joint publications
Santeri Pakola
4 joint publications
Elise Jirovec
3 joint publications
Mirte van der Heijden
3 joint publications
Jorma Sormunen
3 joint publications
Lyna Haybout
2 joint publications
Riikka Havunen
2 joint publications
Victor Arias
2 joint publications
Matthew Stephen Block
2 joint publications
Teijo Pellinen